
From the U.S. Code Online via GPO Access
[wais.access.gpo.gov]
[Laws in effect as of January 23, 2000]
[Document not affected by Public Laws enacted between
  January 23, 2000 and December 4, 2001]
[CITE: 42USC285d-7]

 
                 TITLE 42--THE PUBLIC HEALTH AND WELFARE
 
                    CHAPTER 6A--PUBLIC HEALTH SERVICE
 
              SUBCHAPTER III--NATIONAL RESEARCH INSTITUTES
 
   Part C--Specific Provisions Respecting National Research Institutes
 
subpart 4--national institute of arthritis and musculoskeletal and skin 
                                diseases
 
Sec. 285d-7. Advisory Board


(a) Establishment

    The Secretary shall establish in the Institute the National 
Arthritis and Musculoskeletal and Skin Diseases Advisory Board 
(hereafter in this section referred to as the ``Advisory Board'').

(b) Membership; ex officio members

    The Advisory Board shall be composed of twenty appointed members and 
nonvoting, ex officio members, as follows:
        (1) The Secretary shall appoint--
            (A) twelve members from individuals who are scientists, 
        physicians, and other health professionals, who are not officers 
        or employees of the United States, and who represent the 
        specialties and disciplines relevant to arthritis, 
        musculoskeletal diseases, and skin diseases; and
            (B) eight members from the general public who are 
        knowledgeable with respect to such diseases, including one 
        member who is a person who has such a disease, one person who is 
        the parent of an adult with such a disease, and two members who 
        are parents of children with arthritis.

    Of the appointed members at least five shall by virtue of training 
    or experience be knowledgeable in health education, nursing, data 
    systems, public information, or community program development.
        (2) The following shall be ex officio members of the Advisory 
    Board:
            (A) the Assistant Secretary for Health, the Director of NIH, 
        the Director of the National Institute of Arthritis and 
        Musculoskeletal and Skin Diseases, the Director of the Centers 
        for Disease Control and Prevention, the Under Secretary for 
        Health of the Department of Veterans Affairs, and the Assistant 
        Secretary of Defense for Health Affairs (or the designees of 
        such officers), and
            (B) such other officers and employees of the United States 
        as the Secretary determines necessary for the Advisory Board to 
        carry out its functions.

(c) Compensation

    Members of the Advisory Board who are officers or employees of the 
Federal Government shall serve as members of the Advisory Board without 
compensation in addition to that received in their regular public 
employment. Other members of the Advisory Board shall receive 
compensation at rates not to exceed the daily equivalent of the annual 
rate in effect for grade GS-18 of the General Schedule for each day 
(including traveltime) they are engaged in the performance of their 
duties as members of the Advisory Board.

(d) Term of office; vacancy

    The term of office of an appointed member of the Advisory Board is 
four years. Any member appointed to fill a vacancy for an unexpired term 
shall be appointed for the remainder of such term. A member may serve 
after the expiration of the member's term until a successor has taken 
office. If a vacancy occurs in the Advisory Board, the Secretary shall 
make an appointment to fill the vacancy not later than 90 days after the 
date the vacancy occurred.

(e) Chairman

    The members of the Advisory Board shall select a chairman from among 
the appointed members.

(f) Executive director, professional and clerical staff; administrative 
        support services and facilities

    The Secretary shall, after consultation with and consideration of 
the recommendations of the Advisory Board, provide the Advisory Board 
with an executive director and one other professional staff member. In 
addition, the Secretary shall, after consultation with and consideration 
of the recommendations of the Advisory Board, provide the Advisory Board 
with such additional professional staff members, such clerical staff 
members, and (through contracts or other arrangements) with such 
administrative support services and facilities, such information, and 
such services of consultants, as the Secretary determines are necessary 
for the Advisory Board to carry out its functions.

(g) Meetings

    The Advisory Board shall meet at the call of the chairman or upon 
request of the Director of the Institute, but not less often than four 
times a year.

(h) Duties and functions

    The Advisory Board shall--
        (1) review and evaluate the implementation of the plan prepared 
    under section 285d-1(a) of this title and periodically update the 
    plan to ensure its continuing relevance;
        (2) for the purpose of assuring the most effective use and 
    organization of resources respecting arthritis, musculoskeletal 
    diseases and skin diseases, advise and make recommendations to the 
    Congress, the Secretary, the Director of NIH, the Director of the 
    Institute, and the heads of other appropriate Federal agencies for 
    the implementation and revision of such plan; and
        (3) maintain liaison with other advisory bodies for Federal 
    agencies involved in the implementation of such plan, the 
    interagency coordinating committees for such diseases established 
    under section 285d-4 of this title, and with key non-Federal 
    entities involved in activities affecting the control of such 
    diseases.

(i) Subcommittees; establishment and membership

    In carrying out its functions, the Advisory Board may establish 
subcommittees, convene workshops and conferences, and collect data. Such 
subcommittees may be composed of Advisory Board members and nonmember 
consultants with expertise in the particular area addressed by such 
subcommittees. The subcommittees may hold such meetings as are necessary 
to enable them to carry out their activities.

(j) Annual report

    The Advisory Board shall prepare an annual report for the Secretary 
which--
        (1) describes the Advisory Board's activities in the fiscal year 
    for which the report is made;
        (2) describes and evaluates the progress made in such fiscal 
    year in research, treatment, education, and training with respect to 
    arthritis, musculoskeletal diseases, and skin diseases;
        (3) summarizes and analyzes expenditures made by the Federal 
    Government for activities respecting such diseases in such fiscal 
    year for which the report is made;
        (4) contains the Advisory Board's recommendations (if any) for 
    changes in the plan prepared under section 285d-1 of this title; and
        (5) contains recommendations for expanding the Institute's 
    funding of research directly applicable to the cause, diagnosis, 
    early detection, prevention, control, and treatment of, and 
    rehabilitation of children with arthritis and musculoskeletal 
    diseases.

(k) Termination of predecessor board; time within which to appoint 
        members

    The National Arthritis Advisory Board in existence on November 20, 
1985, shall terminate upon the appointment of a successor Board under 
subsection (a) of this section. The Secretary shall make appointments to 
the Advisory Board established under subsection (a) of this section 
before the expiration of 90 days after November 20, 1985. The member of 
the Board in existence on November 20, 1985, may be appointed, in 
accordance with subsections (b) and (d) of this section, to the Advisory 
Board established under subsection (a) of this section.

(July 1, 1944, ch. 373, title IV, Sec. 442, as added Pub. L. 99-158, 
Sec. 2, Nov. 20, 1985, 99 Stat. 852; amended Pub. L. 102-405, title III, 
Sec. 302(e)(1), Oct. 9, 1992, 106 Stat. 1985; Pub. L. 102-531, title 
III, Sec. 312(d)(7), Oct. 27, 1992, 106 Stat. 3504; Pub. L. 103-43, 
title VII, Sec. 701(d), title XX, Sec. 2008(b)(7), June 10, 1993, 107 
Stat. 162, 211.)


                               Amendments

    1993--Subsec. (a). Pub. L. 103-43, Sec. 701(d)(1), inserted ``and 
Musculoskeletal and Skin Diseases'' after ``Arthritis''.
    Subsec. (b). Pub. L. 103-43, Secs. 701(d)(2), 2008(b)(7), 
substituted ``twenty'' for ``eighteen'' in introductory provisions, 
``eight'' for ``six'' and ``including one member who is a person who has 
such a disease, one person who is the parent of an adult with such a 
disease, and two members who are parents of children with arthritis'' 
for ``including at least one member who is a person who has such a 
disease and one member who is a parent of a person who has such a 
disease'' in par. (1)(B), and ``Department of Veterans Affairs'' for 
``Veterans' Administration'' in par. (2)(A).
    Subsec. (j)(5). Pub. L. 103-43, Sec. 701(d)(3), added par. (5).
    1992--Subsec. (b)(2)(A). Pub. L. 102-531 substituted ``Centers for 
Disease Control and Prevention'' for ``Centers for Disease Control''.
    Pub. L. 102-405 substituted ``Under Secretary for Health'' for 
``Chief Medical Director''.


                     Termination of Advisory Boards

    Advisory boards established after Jan. 5, 1973, to terminate not 
later than the expiration of the 2-year period beginning on the date of 
their establishment, unless, in the case of a board established by the 
President or an officer of the Federal Government, such board is renewed 
by appropriate action prior to the expiration of such 2-year period, or 
in the case of a board established by the Congress, its duration is 
otherwise provided by law. See sections 3(2) and 14 of Pub. L. 92-463, 
Oct. 6, 1972, 86 Stat. 770, 776, set out in the Appendix to Title 5, 
Government Organization and Employees.
    Pub. L. 93-641, Sec. 6, Jan. 4, 1975, 88 Stat. 2275, set out as a 
note under section 217a of this title, provided that an advisory 
committee established pursuant to the Public Health Service Act shall 
terminate at such time as may be specifically prescribed by an Act of 
Congress enacted after Jan. 4, 1975.


         References in Other Laws to GS-16, 17, or 18 Pay Rates

    References in laws to the rates of pay for GS-16, 17, or 18, or to 
maximum rates of pay under the General Schedule, to be considered 
references to rates payable under specified sections of Title 5, 
Government Organization and Employees, see section 529 [title I, 
Sec. 101(c)(1)] of Pub. L. 101-509, set out in a note under section 5376 
of Title 5.
